Latest filing published 09 Jun 2026 for Arcutis Biotherapeutics, Inc.. Read the official filing
Filings by Neha Krishnamohan span 3 companies, the busiest being Kinnate Biopharma Inc., Arcutis Biotherapeutics, Inc. and Artiva Biotherapeutics, Inc. We count 17 filings; the first trade dates from 1 September 2022 and the latest from 5 June 2026.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 9 June 2026: a share grant, in Arcutis Biotherapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
17 of 17 declarations